Evidence map›Paper›PMID 20126404›Full record

ArticlePloS one2010

The high affinity IgE receptor Fc epsilonRI is expressed by human intestinal epithelial cells.

Eva Untersmayr, Giovanna Bises, Philipp Starkl, Charles L Bevins, Otto Scheiner, George Boltz-Nitulescu, Fritz Wrba, Erika Jensen-Jarolim

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. The rationale for development of ligelizumab in food allergy.The World Allergy Organization journal · 2022
    Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Detection of immunoglobulin isotypes from dried blood spots.Journal of immunological methods · 2014
    Article
  13. Article
  14. How to connect an IgE-driven response with CTL activity?Cancer immunology, immunotherapy : CII · 2012
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Eva UntersmayrDepartment of Pathophysiology, Center of Pathophysiology, Infectiology and Immunology, Medical University Vienna, Vienna, Austria. eva.untersmayr@meduniwien.ac.at
Giovanna Bises
Philipp Starkl
Charles L Bevins
Otto Scheiner
George Boltz-Nitulescu
Fritz Wrba
Erika Jensen-Jarolim
Medical University of Vienna · ATUniversity of California, Davis · US

Funding

Novel Defensins in Human Epithelial TissuesR37AI032738 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BEVINS, CHARLES L · 2015 to 2022
$3.1M
Austrian Science Fund FWF F 1808Austrian Science Fund FWF P 18238Austrian Science Fund FWF P 21577NIAID NIH HHS R37 AI032738
6 · The paper itself

Abstract

backgroundIgE antibodies play a paramount role in the pathogenesis of various intestinal disorders. To gain insights in IgE-mediated pathophysiology of the gut, we investigated the expression of the high affinity IgE receptor Fc epsilonRI in human intestinal epithelium. METHODOLOGY/PRINCIPAL

findingsFc epsilonRI alpha-chain, as detected by immunohistochemistry, was positive in epithelial cells for eight of eleven (8/11) specimens from colon cancer patients and 5/11 patients with inflammation of the enteric mucosa. The Fc epsilonRIalpha positive epithelial cells co-expressed Fc epsilonRIgamma, whereas with one exception, none of the samples was positive for the beta-chain in the epithelial layer. The functionality of Fc epsilonRI was confirmed in situ by human IgE binding. In experiments with human intestinal tumor cell lines, subconfluent Caco-2/TC7 and HCT-8 cells were found to express the alpha- and gamma-chains of Fc epsilonRI and to bind IgE, whereas confluent cells were negative for gamma-chains. CONCLUSIONS/SIGNIFICANCE: Our data provide the first evidence that the components of a functional Fc epsilonRI are in vitro expressed by the human intestinal epithelial cells depending on differentiation and, more importantly, in situ in epithelia of patients with colon cancer or gastrointestinal inflammations. Thus, a contribution of Fc epsilonRI either to immunosurveillance or pathophysiology of the intestinal epithelium is suggested.

Indexed as

AdultBinding, CompetitiveBlotting, WesternCaco-2 CellsCell Line, TumorColonic NeoplasmsEpithelial CellsFemaleGastrointestinal TractGene Expression Regulation, NeoplasticHumansImmunoglobulin EImmunohistochemistryInflammationIntestinal MucosaMaleImmunoglobulin EProtein SubunitsReceptors, IgE

Identifiers

PMID20126404
PMCPMC2814858
OpenAlexW2091154569

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.